GlassScriptPhysician profile
Renee T Baughman
NPI 1861478018
$3,340.09
in general payments reported to CMS, 2019-2025
36 companies · $23.44 in 2025
The $23.44 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $235 · 2021: $508 · 2022: $592 · 2023: $626 · 2024: $656 · 2025: $23.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.91 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $429.96 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $415.20 | 2019-2024 | Lo Loestrin Fe |
| Pfizer INC. | $291.03 | 2019-2023 | |
| Gilead Sciences, INC. | $261.67 | 2019-2024 | |
| Amgen INC. | $210.71 | 2019-2024 | Evenity, Prolia |
| Exeltis, USA INC. | $176.88 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $142.20 | 2021-2023 | |
| Exact Sciences Corporation | $129.96 | 2023-2024 | Cologuard Collection Kit |
| Myovant Sciences INC. | $127.20 | 2021-2022 | |
| Sage Therapeutics, LLC | $111.37 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.03 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $98.44 | 2023-2024 | Myfembree, Gemtesa |
| Agile Therapeutics, INC. | $90.54 | 2021-2024 | Twirla |
| Millicent US INC | $88.99 | 2019-2024 | |
| Therapeuticsmd, INC. | $75.09 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $59.27 | 2019-2024 | Gardasil 9, Gardasil |
| Amag Pharmaceuticals, INC. | $44.93 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $44.28 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.08 | 2019-2020 | |
| Avion Pharmaceuticals | $41.21 | 2019 | |
| Hologic Sales and Service, LLC | $39.06 | 2021-2024 | Aptima |
| Allergan, INC. | $30.19 | 2019-2020 | |
| Organon LLC | $29.15 | 2024-2025 | Jada System |
| Alexion Pharmaceuticals, INC. | $27.55 | 2019 | |
| Boston Scientific Corporation | $27.16 | 2023 | Watchman Flx |
| Evofem Biosciences, INC. | $24.27 | 2021 | |
| Daiichi Sankyo INC. | $23.38 | 2023 | Injectafer |
| Glaxosmithkline, LLC. | $22.58 | 2022 | |
| Scynexis, INC. | $21.31 | 2022 | |
| Biogen, INC. | $19.27 | 2023 | |
| Olympus America INC. | $17.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.47 | 2019 | |
| Baxter Healthcare | $16.38 | 2024 | Perclot |
| Duchesnay USA Incorporated | $14.07 | 2019 | |
| Urovant Sciences INC | $14.05 | 2021 | |
| Lupin INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Baughman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.